What does CUSIP 03969K108 represent in this 13F holders report?

CUSIP 03969K108 is the security identifier for ARQT - Arcutis Biotherapeutics, Inc. - Common used to aggregate holder disclosures.

How many institutions held ARQT - Arcutis Biotherapeutics, Inc. - Common in Q1 2021?

93 institutional investors reported ARQT - Arcutis Biotherapeutics, Inc. - Common for Q1 2021. Use the holders table for investor-level position and value details.

Arcutis Biotherapeutics, Inc. - Common (ARQT)

CUSIP: 03969K108

Q1 2021 13F Holders as of 31 Mar 2021

Type / Class: Equity / Common
Shares outstanding: 123,318,907
Total 13F shares: 46,841,365
Share change: +5,867,646
Total reported value: $1,354,985,371
Put/Call ratio: 90%
Price per share: $28.93
Number of holders: 93
Value change: +$170,660,745
Number of buys: 65
Number of sells: 23

Quarterly Holders Quick Answers

What is CUSIP 03969K108?
CUSIP 03969K108 identifies ARQT - Arcutis Biotherapeutics, Inc. - Common in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2021
Previous quarter: Q4 2020

Recent filing periods for CUSIP 03969K108:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of ARQT - Arcutis Biotherapeutics, Inc. - Common (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
FRAZIER MANAGEMENT LLC	13F	Company	8.5%	10,542,790	$296,569,000	—	31 Dec 2020	13F
FMR LLC	13F	Company	5.3%	6,545,156	$184,116,000	—	31 Dec 2020	13F
ORBIMED ADVISORS LLC	13F	Company	4.9%	6,073,850	$170,857,000	—	31 Dec 2020	13F
Bain Capital Life Sciences Investors, LLC	13F	Company	3.2%	3,979,292	$111,937,000	—	31 Dec 2020	13F
BlackRock Finance, Inc.	13F	Company	2.3%	2,895,054	$81,437,000	—	31 Dec 2020	13F
RA CAPITAL MANAGEMENT, L.P.	13F	Company	0.94%	1,165,184	$32,777,000	—	31 Dec 2020	13F
VANGUARD GROUP INC	13F	Company	0.88%	1,087,133	$30,581,000	—	31 Dec 2020	13F
Point72 Asset Management, L.P.	13F	Company	0.71%	875,200	$24,619,000	—	31 Dec 2020	13F
Vivo Capital, LLC	13F	Company	0.7%	867,170	$24,393,000	—	31 Dec 2020	13F
STATE STREET CORP	13F	Company	0.68%	839,022	$23,602,000	—	31 Dec 2020	13F
Polar Capital Holdings Plc	13F	Company	0.63%	775,000	$21,801,000	—	31 Dec 2020	13F
Pivotal bioVenture Partners Investment Advisor LLC	13F	Company	0.54%	671,716	$18,895,000	—	31 Dec 2020	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.52%	643,456	$18,101,000	—	31 Dec 2020	13F
Omega Fund Management, LLC	13F	Company	0.52%	640,199	$18,009,000	—	31 Dec 2020	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.27%	338,152	$9,512,000	—	31 Dec 2020	13F
AMERICAN CENTURY COMPANIES INC	13F	Company	0.23%	288,300	$8,110,000	—	31 Dec 2020	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	0.21%	262,781	$7,392,000	—	31 Dec 2020	13F
NORTHERN TRUST CORP	13F	Company	0.19%	240,255	$6,758,000	—	31 Dec 2020	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.18%	224,765	$6,322,000	—	31 Dec 2020	13F
Nuveen Asset Management, LLC	13F	Company	0.15%	180,642	$5,082,000	—	31 Dec 2020	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.13%	160,094	$4,503,000	—	31 Dec 2020	13F
MORGAN STANLEY	13F	Company	0.12%	152,010	$4,277,000	—	31 Dec 2020	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.11%	141,439	$3,979,000	—	31 Dec 2020	13F
CITADEL ADVISORS LLC	13F	Company	0.11%	133,703	$3,761,000	—	31 Dec 2020	13F
DEUTSCHE BANK AG\	13F	Company	0.09%	115,935	$3,261,000	—	31 Dec 2020	13F
AMERIPRISE FINANCIAL INC	13F	Company	0.09%	115,117	$3,238,000	—	31 Dec 2020	13F
Octagon Capital Advisors LP	13F	Company	0.08%	100,000	$2,813,000	—	31 Dec 2020	13F
MARSHALL WACE, LLP	13F	Company	0.06%	78,973	$2,222,000	—	31 Dec 2020	13F
ALPS ADVISORS INC	13F	Company	0.06%	69,025	$1,942,000	—	31 Dec 2020	13F
Bank of New York Mellon Corp	13F	Company	0.05%	66,527	$1,871,000	—	31 Dec 2020	13F
Altium Capital Management LLC	13F	Company	0.05%	62,962	$1,771,000	—	31 Dec 2020	13F
Laurion Capital Management LP	13F	Company	0.04%	50,000	$1,407,000	—	31 Dec 2020	13F
Squarepoint Ops LLC	13F	Company	0.04%	49,082	$1,381,000	—	31 Dec 2020	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.04%	48,830	$1,374,000	—	31 Dec 2020	13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM	13F	Company	0.03%	40,604	$1,142,000	—	31 Dec 2020	13F
Ensign Peak Advisors, Inc	13F	Company	0.03%	38,604	$1,086,000	—	31 Dec 2020	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.03%	31,322	$881,000	—	31 Dec 2020	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.02%	29,300	$824,000	—	31 Dec 2020	13F
STATE OF WISCONSIN INVESTMENT BOARD	13F	Company	0.02%	25,300	$712,000	—	31 Dec 2020	13F
CREDIT SUISSE AG/	13F	Company	0.02%	24,608	$692,000	—	31 Dec 2020	13F
Swiss National Bank	13F	Company	0.02%	24,300	$684,000	—	31 Dec 2020	13F
NORGES BANK	13F	Company	0.02%	21,116	$594,000	—	31 Dec 2020	13F
Marshall Wace North America L.P.	13F	Company	0.02%	20,661	$581,000	—	31 Dec 2020	13F
RHUMBLINE ADVISERS	13F	Company	0.02%	20,088	$565,000	—	31 Dec 2020	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	0.01%	18,200	$512,000	—	31 Dec 2020	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.01%	15,800	$444,000	—	31 Dec 2020	13F
Deutsche Girozentrale DekaBank	13F	Individual	0.01%	12,400	$358,000	—	31 Dec 2020	13F
OCCUDO QUANTITATIVE STRATEGIES LP	13F	Company	0.01%	12,521	$352,000	—	31 Dec 2020	13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE	13F	Company	0.01%	12,087	$340,000	—	31 Dec 2020	13F
AMERICAN INTERNATIONAL GROUP, INC.	13F	Company	0.01%	12,038	$339,000	—	31 Dec 2020	13F

Institutional Holders of Arcutis Biotherapeutics, Inc. - Common (ARQT) as of Q1 2021

As of 31 Mar 2021, Arcutis Biotherapeutics, Inc. - Common (ARQT) was held by 93 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 46,841,365 shares. The largest 10 holders included FRAZIER MANAGEMENT LLC, FMR LLC, ORBIMED ADVISORS LLC, BlackRock Inc., Bain Capital Life Sciences Investors, LLC, Polar Capital Holdings Plc, VANGUARD GROUP INC, STATE STREET CORP, Sectoral Asset Management Inc, and WELLS FARGO & COMPANY/MN. This page lists 93 institutional shareholders reporting positions in this security for the Q1 2021 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2021 vs Q4 2020 Across Filers

Q4 2020 holders

Q1 2021 holders

Holder diff

Investor	Q4 2020 Shares	Q1 2021 Shares	Share Diff	Share Chg %	Q4 2020 Value $	Q1 2021 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.